Is estradiol vaginal cream (estrogen) safe in a patient with a history (h/o) of breast cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Estradiol vaginal cream can be considered safe for patients with a history of breast cancer, particularly those with hormone-receptor positive breast cancer, as a large cohort study of almost 50,000 patients with breast cancer followed for up to 20 years showed no evidence of a higher risk of breast cancer-specific mortality in those using vaginal estrogen 1. However, it is essential to weigh the benefits and risks of using estrogen-containing products in breast cancer survivors, as the potential stimulation of residual cancer cells is a concern. The use of vaginal estrogen has been shown to be effective in treating vaginal dryness, itching, discomfort, and painful intercourse in postmenopausal individuals, including breast cancer survivors 1. Some key points to consider when deciding on the use of estradiol vaginal cream in patients with a history of breast cancer include:

  • The level of estrogen absorption can be variable, which raises concerns in patients with a history of breast cancer 1
  • Non-hormonal options, such as vaginal moisturizers and lubricants, should be tried first for vaginal symptoms
  • Low-dose vaginal estrogen preparations, such as ultra-low dose estradiol vaginal preparations (e.g., Vagifem 10 mcg tablets or Imvexxy 4 mcg inserts), may be safer alternatives to cream formulations 1
  • Ospemifene or DHEA vaginal inserts (prasterone) offer non-estrogen approaches to treating vaginal symptoms and may be considered for some patients 1
  • Any decision to use hormonal therapy should involve shared decision-making with the patient and coordination between gynecology and oncology providers 1

From the FDA Drug Label

CONTRAINDICATIONS Estradiol valerate injection, USP should not be used in women with any of the following conditions: ... Known, suspected, or history of cancer of the breast.

Who should not take Estradiol valerate injection, USP ? Do not start taking Estradiol valerate injection, USP if you: ... have or had certain cancers. Estrogens may increase the chances of getting certain types of cancers, including cancer of the breast or uterus. If you have or had cancer, talk with your healthcare provider about whether you should take Estradiol valerate injection, USP .

The use of estrogen in a patient with a history of breast cancer is contraindicated, as it may increase the risk of cancer recurrence. Therefore, estradiol vaginal cream is not safe for a patient with a history of breast cancer 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.